Crude extract and isolated bioactive compounds from Notholirion thomsonianum (Royale) Stapf as multitargets antidiabetic agents: in-vitro and molecular docking approaches

MLA

Mater H. Mahnashi, et al. “Crude Extract and Isolated Bioactive Compounds from Notholirion Thomsonianum (Royale) Stapf as Multitargets Antidiabetic Agents: In-Vitro and Molecular Docking Approaches.” BMC Complementary Medicine and Therapies, vol. 21, no. 1, Oct. 2021, pp. 1–13. EBSCOhost, https://doi.org/10.1186/s12906-021-03443-7.

APA

Mater H. Mahnashi, Yahya S. Alqahtani, Ali O. Alqarni, Bandar A. Alyami, Muhammad Saeed Jan, Muhammad Ayaz, Farhat Ullah, Umer Rashid, & Abdul Sadiq. (2021). Crude extract and isolated bioactive compounds from Notholirion thomsonianum (Royale) Stapf as multitargets antidiabetic agents: in-vitro and molecular docking approaches. BMC Complementary Medicine and Therapies, 21(1), 1–13. https://doi.org/10.1186/s12906-021-03443-7

Chicago

Mater H. Mahnashi, Yahya S. Alqahtani, Ali O. Alqarni, Bandar A. Alyami, Muhammad Saeed Jan, Muhammad Ayaz, Farhat Ullah, Umer Rashid, and Abdul Sadiq. 2021. “Crude Extract and Isolated Bioactive Compounds from Notholirion Thomsonianum (Royale) Stapf as Multitargets Antidiabetic Agents: In-Vitro and Molecular Docking Approaches.” BMC Complementary Medicine and Therapies 21 (1): 1–13. doi:10.1186/s12906-021-03443-7.